Analysts’ downgrades for Thursday, August 10th:
Saul Centers (NYSE:BFS) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “SAUL CENTERS, INC. is a real estate investment trust which is engaged in the management and development of the shopping center business of the Saul Organization. “
Brookdale Senior Living (NYSE:BKD) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Brookdale Senior Living Inc. is a leading owner and operator of senior living facilities throughout the United States. The Company is committed to providing an exceptional living experience through properties that are designed, purpose-built and operated to provide the highest-quality service, care and living accommodations for residents. The Company owns and operates independent, assisted and dementia-care facilities. “
Coeur Mining (NYSE:CDE) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Coeur Mining, Inc. operates as a primary silver and gold producer with precious metals mines in the Americas. The company’s principal properties include the Palmarejo silver-gold mine in Mexico, the San Bartolome silver mine in Bolivia, the Rochester silver-gold mine in Nevada and the Kensington gold mine in Alaska. It also conducts ongoing exploration activities in Alaska, Argentina, Bolivia, Mexico, and Nevada. Coeur Mining, Inc., formerly known as Coeur d’Alene Mines Corporation, is headquartered in Chicago, Illinois. “
Cellectis (NASDAQ:CLLS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France. “
Chimerix (NASDAQ:CMRX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Chimerix, Inc. engages in the discovery, development and commercialization of oral antiviral therapeutics for various medical needs. The Company is developing various product candidates for the treatment of dsDNA viruses, HIV, hepatitis C, influenza and smallpox which are under different phases of clinical development. It is also screening our proprietary Chimerix Chemical Library for compounds with activity against dengue virus, malaria and tuberculosis. Chimerix, Inc. is headquartered in Durham, North Carolina. “
CNH Industrial NV (NASDAQ:CNHI) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “CNH Industrial NV designs, produces and sells trucks, commercial vehicles, buses, special vehicles, agricultural and construction equipment, in addition to engines and transmissions for those vehicles and engines for marine application. CNH Industrial NV is based in Amsterdam, the Netherlands. “
Ceragon Networks (NASDAQ:CRNT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Ceragon Networks Ltd. is a leading provider of high-capacity wireless backhaul solutions for cellular and fixed wireless operators, enterprises and government organizations. Ceragon’s modular FibeAir product family is recognized as the gold standard for backhaul transmission and is also one of the top solutions chosen by cellular operators for SONET/SDH rings. A scalable, future-proof solution for wireless transport of broadband services, FibeAir operates across multiple frequencies for IP and SONET/SDH protocols, supporting the emerging needs of next-generation networks that are evolving to all-IP based services, including triple-play. It leads the market in IP backhaul, offering a unique, native IP solution that provides the efficient, robust connectivity required for WiFi, WiMAX and converged networks. “
Diamondrock Hospitality (NYSE:DRH) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “DiamondRock Hospitality Company is a self-advised real estate company that owns, acquires and invests in upper upscale and upscale hotel properties located primarily in North America. To a lesser extent, it may invest, on a selective basis, in premium limited-service and extended-stay hotel properties in urban locations. The Company has a strategic acquisition sourcing relationship with Marriott International. “
Esperion Therapeutics (NASDAQ:ESPR) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Esperion Therapeutics, Inc. is a biopharmaceutical company. It focused on the research, development and commercialization of therapies for low-density lipoprotein cholesterol and other cardiometabolic risk factors. Esperion Therapeutics, Inc. is based in Plymouth, Michigan. “
Evolent Health (NYSE:EVH) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. “
